Prot #M15-954: A Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)

Project: Research project

Project Details

StatusActive
Effective start/end date12/1/20 → 12/1/24

Funding

  • AbbVie Inc. (Prot #M15-954)